Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

146
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
146
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

154
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
154
Assessment of Ventilation I: Respiratory Rate01:20

Assessment of Ventilation I: Respiratory Rate

967
Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
967
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

146
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The longitudinal decrease in exercise tolerance and disease progression in mild-to-moderate COPD.

Respiratory medicine·2026
Same author

Research Progress on the Alkaloids of <i>Dendrobium nobile</i>: Substantiation, Key Components, Pharmacological Activity, and Biosynthetic Pathways.

Current issues in molecular biology·2026
Same author

Clinical characteristics and longitudinal prognosis of patients with mild-to-moderate chronic obstructive pulmonary disease progressing from different lung function trajectories.

Journal of thoracic disease·2026
Same author

Rapid decline in lung function is associated with more chronic respiratory symptoms, more severe small airway dysfunction and lung structural changes.

Journal of thoracic disease·2026
Same author

Compartment-specific phase compensation between pulmonary T-Cell immunity and waning systemic responses in BA.5 breakthrough infection.

Respiratory research·2026
Same author

Prognostic Significance of Mild Exacerbations or 1 Moderate Exacerbation in COPD: A Prospective Community-Based Cohort Study.

Chest·2026

Related Experiment Video

Updated: May 15, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K

Impaired Ventilatory Efficiency Identifies High-Risk Mild-to-Moderate Chronic Obstructive Pulmonary Disease.

Zhishan Deng1, Fan Wu1, Qi Wan1

  • 1State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & Guangzhou Institute of Respiratory Health & National Center for Respiratory Medicine & Hengqin Hospital, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.

Archivos De Bronconeumologia
|May 13, 2025
PubMed
Summary

Impaired ventilatory efficiency identifies high-risk COPD patients with faster lung function decline and more exacerbations. This finding is independent of other known risk factors, aiding in early identification and management strategies.

Keywords:
Chronic obstructive pulmonary diseaseExacerbation risksImpaired ventilatory efficiencyLung function declineSymptomTreatable trait

More Related Videos

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

596
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

1.4K

Related Experiment Videos

Last Updated: May 15, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

596
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

1.4K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • Identifying high-risk patients is crucial for managing mild-to-moderate COPD.
  • Impaired ventilatory efficiency is observed in over 20% of these patients.
  • The prognostic value of impaired ventilatory efficiency for high-risk identification remains unclear.

Purpose of the Study:

  • To investigate the prognostic value of impaired ventilatory efficiency in mild-to-moderate COPD.
  • To determine if impaired ventilatory efficiency independently predicts poor outcomes in COPD patients.

Main Methods:

  • Prospective cohort study in China (2019-2024) including COPD patients and non-COPD controls.
  • Exclusion of subjects meeting predefined high-risk criteria.
  • Assessment of ventilatory efficiency using cardiopulmonary exercise tests, with outcomes including lung function decline, exacerbation risk, and symptom scores over 3 years.

Main Results:

  • Patients with impaired ventilatory efficiency showed a significantly greater annual decline in postbronchodilator FEV1 (54 mL/year) compared to those with normal efficiency (31 mL/year).
  • Similar trends were observed for increased exacerbation risks and symptom scores in patients with impaired ventilatory efficiency.
  • No significant difference in outcomes was found between COPD patients with normal ventilatory efficiency and non-COPD subjects.

Conclusions:

  • Impaired ventilatory efficiency serves as an independent marker for identifying high-risk mild-to-moderate COPD patients.
  • These patients exhibit a poorer prognosis, characterized by accelerated disease progression.
  • Further research is warranted to develop targeted interventions for individuals with impaired ventilatory efficiency.